what we do
Work With Us
EVERY DAY, the CytoSolve® Collaboratory™ Integrates Molecular Pathways Derived from In Vitro and In Vivo Scientific Experiments Being Conducted Worldwide
We Provide the 21st Century Platform for Discovery and Development of Therapeutics for Atherosclerosis
AtheroSolve
AtheroSolve™ provides technology and services towards accelerating drug development using an integrative platform for quantitative modeling of...
Learn more
CytoSolve
CytoSolve® is revolutionizing health by accelerating development, discovery and delivery of therapeutics, nutraceuticals and functional...
Learn more
Partner
To be Announced
Learn more
Dr. V.A. Shiva Ayyadurai Delivers State of the Art Lecture at ASCPT Annual Meeting, 2017
Dr. V.A. Shiva Ayyadurai speaks about CytoSolve at FasterCures’ Distinguished Panel on Redefining Discovery for the 21st Century
We Deliver Innovative Solutions
Research Areas
Target Identification
Traditional methods of target discovery have relied on in vitro/ in vivo studies and sometimes molecular dynamics analysis. However, these methods are ad hoc and do...
Read more
Combination Therapeutics
Recent research has focused on identifying combination of drugs or dietary supplements with maximum effect at minimal dosage levels. However, the in vitro and in vivo...
Read more
Drug Repurposing
Discoveries about the molecular basis of disease provide unprecedented opportunities to find new medicines. Discovery and formulation of new drug takes more than 14...
Read more
Biomarkers
Mechanistic understanding of complex biological phenomena is needed at a system level to identify novel biomarkers that can be used for better diagnostics of a...
Read more
Safety and Toxicity
Diverse responses of target or biomarker induced toxicity through different signaling pathways are identified through systematic literature review. Computational...
Read more